117 related articles for article (PubMed ID: 27956461)
1. L-DOPA therapy interferes with urine catecholamine analysis in children with suspected neuroblastoma: a case series.
Kelly AU; Srivastava R; Dow E; Davidson DF
Ann Clin Biochem; 2017 Sep; 54(5):616-621. PubMed ID: 27956461
[TBL] [Abstract][Full Text] [Related]
2. Parkinson's disease: the effect of L-dopa therapy on urinary free catecholamines and metabolites.
Davidson DF; Grosset K; Grosset D
Ann Clin Biochem; 2007 Jul; 44(Pt 4):364-8. PubMed ID: 17594783
[TBL] [Abstract][Full Text] [Related]
3. Neuroblastoma--when are urinary catecholamines and their metabolites 'normal'?
Worthington DJ; Hammond EM; Eldeeb BB; Green A; Addison GM; Jones PH; Mann JR
Ann Clin Biochem; 1988 Nov; 25 ( Pt 6)():620-6. PubMed ID: 3254101
[TBL] [Abstract][Full Text] [Related]
4. Age-related medical decision limits for urinary free (unconjugated) metadrenalines, catecholamines and metabolites in random urine specimens from children.
Davidson DF; Hammond PJ; Murphy D; Carachi R
Ann Clin Biochem; 2011 Jul; 48(Pt 4):358-66. PubMed ID: 21670092
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous determination of catecholamines and metanephrines in urine by HPLC with fluorometric detection.
Abeling NG; van Gennip AH; Overmars H; Voûte PA
Clin Chim Acta; 1984 Feb; 137(2):211-26. PubMed ID: 6705234
[TBL] [Abstract][Full Text] [Related]
6. Urinary catecholamines and their metabolites in management of neuroblastoma.
Eldeeb BB; Hammond EM; Worthington DJ; Mann JR
Pediatr Hematol Oncol; 1988; 5(3):229-37. PubMed ID: 3152967
[TBL] [Abstract][Full Text] [Related]
7. Initial urinary catecholamine metabolite concentrations and prognosis in neuroblastoma.
Laug WE; Siegel SE; Shaw KN; Landing B; Baptista J; Gutenstein M
Pediatrics; 1978 Jul; 62(1):77-83. PubMed ID: 683787
[TBL] [Abstract][Full Text] [Related]
8. Conjugated versus "free" acidic metabolites of catecholamines in random urine samples: significance for the diagnosis of neuroblastoma.
Tuchman M; Stoeckeler JS
Pediatr Res; 1988 Jun; 23(6):576-9. PubMed ID: 3393388
[TBL] [Abstract][Full Text] [Related]
9. [Diurnal urine excretion of catecholamines and DOPA in tumors of the sympathetic nervous system in children].
Kharchenko AD; Kniazev IuA; Bukhny AE; Kovalev GP; Kosiakov GA
Pediatriia; 1969 May; 48(5):51-4. PubMed ID: 4309285
[No Abstract] [Full Text] [Related]
10. Plasma dopa and catecholamines in the diagnosis and follow-up of children with neuroblastoma.
Alvarado CS; Faraj BA; Kim TH; Camp VM; Bain RP; Ragab AH
Am J Pediatr Hematol Oncol; 1985; 7(3):221-7. PubMed ID: 3934994
[TBL] [Abstract][Full Text] [Related]
11. The secretion of ibuprofen metabolites interferes with the capillary chromatography of urinary homovanillic acid and 4-hydroxy-3-methoxymandelic acid in neuroblastoma diagnosis.
Levreri I; Caruso U; Deiana F; Buoncompagni A; De Bernardi B; Marchese N; Melioli G
Clin Chem Lab Med; 2005; 43(2):173-7. PubMed ID: 15843212
[TBL] [Abstract][Full Text] [Related]
12. [Sensitivity and specificity of the determination of urinary catecholamines and their acid metabolites in the diagnosis of neuroblastoma in children].
Horsmans Y; Desager JP; Harvengt C
Bull Cancer; 1990; 77(10):985-9. PubMed ID: 2249018
[TBL] [Abstract][Full Text] [Related]
13. [Recommended methods for the determination of catecholamines and their metabolites in urine. Significance of results in the diagnosis and follow-up of pheochromocytoma and neuroblastoma].
Revol A; Comoy E; Forzy G; Garnier JP; Gerhardt MF; Hirth C; Jacob N; Mathieu P; Patricot MC; Peyrin L
Ann Biol Clin (Paris); 1994; 52(9):625-37. PubMed ID: 7872511
[TBL] [Abstract][Full Text] [Related]
14. [The importance of the determination of urinary catecholamines and urinary vanilmandelic acid in the diagnosis and control of neuroblastoma therapy].
Rutiloni C; Serra GB
Minerva Pediatr; 1968 Dec; 20(48):2481-7. PubMed ID: 5715834
[No Abstract] [Full Text] [Related]
15. Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients.
Strenger V; Kerbl R; Dornbusch HJ; Ladenstein R; Ambros PF; Ambros IM; Urban C
Pediatr Blood Cancer; 2007 May; 48(5):504-9. PubMed ID: 16732582
[TBL] [Abstract][Full Text] [Related]
16. Interpretation of random urinary catecholamines and their metabolites in neuroblastoma.
O'Meara A; Tormey W; FitzGerald RJ; Fitzgibbon M; Kenny D
Acta Paediatr; 1994 Jan; 83(1):88-92. PubMed ID: 8193481
[TBL] [Abstract][Full Text] [Related]
17. Mass-spectrometry determination of urinary catecholamine metabolites children with neuroblastoma.
Lucarelli C; Boniforti L; Castello MA; Clerico A
Ann Ist Super Sanita; 1983; 19(4):655-9. PubMed ID: 6544590
[No Abstract] [Full Text] [Related]
18. Paediatric reference ranges for urinary catecholamines/metabolites and their relevance in neuroblastoma diagnosis.
Fitzgibbon MC; Tormey WP
Ann Clin Biochem; 1994 Jan; 31 ( Pt 1)():1-11. PubMed ID: 8154845
[No Abstract] [Full Text] [Related]
19. [Excretion of catecholamines and their metabolites in children with neuroblastoma].
Prokopczyk J; Wańkowicz B; Wenzel E
Pediatr Pol; 1979 Aug; 54(8):853-9. PubMed ID: 503668
[No Abstract] [Full Text] [Related]
20. Urinary free catecholamines--diagnostic application of an HPLC technique to the investigation of neural crest tumours.
Davidson DF
Ann Clin Biochem; 1987 Sep; 24 ( Pt 5)():494-9. PubMed ID: 3662400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
